News|Articles|August 1, 2018

In the Lab eNewsletter

  • Pharmaceutical Technology\'s In the Lab eNewsletter-09-05-2018
  • Volume 13
  • Issue 9

Metrohm Acquires B&W Tek

The acquisition will increase Metrohm’s spectroscopy offerings and capabilities.

On July 27, 2018, Metrohm AG, a manufacturer of high-precision instruments for chemical analysis, announced that it acquired B&W Tek’s spectroscopy solution business, B&W Tek, as well as several subsidiaries. B&W Tek is a provider of Raman spectroscopy solutions as well as laser-induced breakdown spectroscopy technology, near-infrared spectroscopy, and ultraviolet–visible spectroscopy/ultraviolet–visible spectrometers and solutions.

According to Metrohm, the acquisition contributes to the development of the company’s Raman product line as well as the company’s overall growth strategy. Financial details of the transaction were not disclosed. 

B&W Tek will continue to operate under its own brand with its own sales and service organization for the time being to avoid any business disruption. After this transition period, B&W Tek will be gradually integrated into the Metrohm organization.

Source: Metrohm


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.